Benzodiazepine Prescribing in Wyoming
Medicare Part D, 2013–2024.
Benzodiazepine prescribing in Wyoming fell 9.6% between 2013 and 2024 — a slower fall than the country as a whole. In 2024 the state recorded 32,049 Medicare Part D benzodiazepine claims across 7,696 patients, an average of 4.16 fills per patient per year, which ranks 42 of 51 states. Lorazepam accounts for 28.1% of it.
Wyoming over twelve years
Which benzodiazepines Wyoming prescribes
| Drug | Claims 2024 | Share |
|---|---|---|
| Lorazepam | 8,991 | 28.1% |
| Alprazolam | 8,573 | 26.7% |
| Clonazepam | 8,069 | 25.2% |
| Diazepam | 4,372 | 13.6% |
| Temazepam | 1,734 | 5.4% |
Psychiatric prescribers in Wyoming
15 psychiatric prescribers in Wyoming appear in the 2024 Medicare Part D data with benzodiazepine claims. 3 of them recorded at least a 50% fall in benzodiazepine claims since 2019. Sorted by change, largest reduction first.
This is a record, not a recommendation. A fall in Medicare benzodiazepine claims has many possible explanations — a changing patient panel, retirement, a shift to another payer, or simply dropping below the threshold CMS publishes. It does not establish that a prescriber supports tapering, and a low number does not mean they will take you as a patient. Use it as one input, then ask the five vetting questions.
| Prescriber | City | 2019 | 2024 | Change |
|---|---|---|---|---|
| Sandra NelsonPsychiatry | Cody | 98 | 12 | -87.8% |
| Christopher ReyburnPsychiatry | Laramie | 33 | 11 | -66.7% |
| Jason CollisonPsychiatry | Cheyenne | 106 | 38 | -64.2% |
| Cheryl PortwoodPsychiatry | Lander | 181 | 102 | -43.6% |
| Mary MorenoPsychiatry | Laramie | 40 | 24 | -40% |
| Jiri DanczikPsychiatry | Casper | 178 | 117 | -34.3% |
| Scott PollardPsychiatry | Cody | 424 | 331 | -21.9% |
| Jie ChenPsychiatry | Casper | 127 | 102 | -19.7% |
| Kathryn HopfenspergerPsychiatry | Cheyenne | 370 | 334 | -9.7% |
| Arlene ShanklinPsychiatry | Cheyenne | 232 | 274 | +18.1% |
| Mark VuoloPsychiatry & Neurology | Casper | 14 | 26 | +85.7% |
| Amy ButterworthPsychiatry | Cheyenne | — | 106 | — |
| William SalmonPsychiatry | Gillette | — | 24 | — |
| William EgbertPsychiatry | Gillette | — | 18 | — |
| Ryan VothPsychiatry & Neurology | Fe Warren Afb | 25 | 813 | +3152% |
Figures are reproduced from the CMS public use files without alteration. Clinicians who believe a row misstates their record can write to support@taperoffbenzos.com and we will check it against the source file and correct or remove it.
Finding a prescriber in Wyoming
This data describes prescribing patterns; it does not tell you who will support a slow taper. For that, our guide to finding a benzo-wise prescriber compares every free provider directory that exists and lists the five questions that predict how a taper will go. If you already have a prescriber, the taper calculator generates a schedule to review with them.
Frequently asked questions
Is benzodiazepine prescribing rising or falling in Wyoming?
It fell 9.6% between 2013 and 2024 in Medicare Part D — a slower fall than the country as a whole, where prescribing fell 12.9%. In 2024, Wyoming recorded 32,049 benzodiazepine claims across 7,696 patients.
How does Wyoming compare to other states?
Wyoming ranks 42 of 51 for prescribing intensity, at 4.16 benzodiazepine fills per patient per year, and 29 of 51 for the size of its decline since 2013 (1 being the steepest fall).
Which benzodiazepine is prescribed most in Wyoming?
Lorazepam, at 8,991 claims — 28.1% of the state's benzodiazepine prescribing in 2024. Next are Alprazolam (26.7%) and Clonazepam (25.2%).
Source
CMS Medicare Part D Prescribers public use files, data years 2013–2024 (US Government work, public domain). Medicare Part D only — it excludes commercial insurance and cash-pay, skews toward patients 65 and over, and suppresses cells of 10 or fewer claims. Full methodology and limitations are on the national page.